Summary:
A Phase II, double-blind study investigating an oral treatment option for treatment of mild memory loss and/or mild Alzheimer's Disease.
Qualified Participants Must:
• Be 55 to 80 years of age, inclusive
•
Have mild to moderate memory loss
•
Complete an MRI
Qualified Participants May Receive:
Compensation for time and travel.
Study-related care at no cost.